Bass, Berry & Sims attorney Richard Mattern answered questions for a Medical Product Outsourcing article detailing the future of the M&A space in 2017. Richard discussed the potential for 2017 to be a strong year for medical device M&A, due in part to near-complete integration efforts of prior years, allowing management to focus on pursuing opportunities. “Capital remains relatively accessible as interest rates remain at near historic lows, the IPO market remains choppy, significant cash is sitting on public balance sheets, and private equity continues to invest in the sector,” Richard said. “The Trump administration appears committed to scaling back regulation, including the potential repeal of the medical device tax, and lowering corporate tax rates.”
The full article, “A Legal Eye’s View of Medtech M&A,” was published by Medical Product Outsourcing on March 30, 2017, and is available online.